International Psoriasis Council

International Psoriasis Council
subscribe
5   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

IPC Welcomes New Councilors Michael Garshick and Andre Ribeiro

Two New Councilors Bring Distinct Perspectives on Psoriatic Disease

The International Psoriasis Council (IPC) welcomes two new Councilors whose work reflects the evolving understanding of psoriatic disease, its systemic impact, and the importance of multidisciplinary, globally informed care.

Michael Garshick and André Ribeiro join IPC’s Council, bringing complementary expertise in cardiovascular comorbidities, psoriatic arthritis, and international clinical education, areas that are increasingly central to improving long-term outcomes for people living with psoriasis.

Michael Garshick, MD

NYU Langone Health

New York, New York, United States

Bio
Dr. Garshick brings a cardiology lens to IPC’s work, focusing on the elevated cardiovascular risk associated with psoriasis and other immune-mediated inflammatory diseases. As a cardiologist with appointments in both medicine and dermatology at NYU Langone Health, his research examines inflammatory mechanisms such as platelet activation and endothelial dysfunction, and he leads an integrated cardio-rheumatology program dedicated to reducing cardiovascular risk in patients with chronic systemic inflammation.

André Lucas Ribeiro, MD

Hospital de Clínicas de Porto Alegre

Porto Alegre, Brazil

Bio
Dr. Ribeiro adds an international and systems-focused perspective, with clinical and research experience spanning Brazil, the United States, and Canada. His work centers on psoriatic arthritis, access to care, and multidisciplinary disease management, and he currently serves as President of Young-GRAPPA (2024–2026), reflecting his commitment to global education and the next generation of clinician leaders.

Strengthening IPC’s Global Perspective

Together, these new Councilors broaden IPC’s expertise across key dimensions of psoriatic disease, supporting the organization’s mission to improve patient outcomes and equip healthcare professionals worldwide with evidence-based, patient-centered guidance.

Categories

Recent Posts

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment Response, and Immune Escape in Psoriasis

VIEW

Approaching Challenging Patient Interactions with Empathy

VIEW

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe

What's New

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Wednesday, May 27, 2026